Last updated: March 2, 2021
Sponsor: Afyonkarahisar Health Sciences University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Neuroblastoma
Retinoblastoma
Treatment
N/AClinical Study ID
NCT04784026
2021/144
Ages 6-18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Healthy control group:
- Being in the age range of 6-18,
- To be physically, cognitively and mentally healthy,
- Open to communication enough to understand questions,
- Speaking and understanding Turkish,
- Approval has been obtained from the child and his / her family for the study and whoagrees to participate in the study, Case group:
- Able to walk alone without any walking aid,
- Open to communication enough to understand questions,
- Speaking and understanding Turkish,
- Approval has been obtained from the child and his / her family for the study and whoagrees to participate in the study,
- Children between the ages of 6-18 will be included in the study
Exclusion
Exclusion Criteria: Healthy control group:
- Any orthopedic or neurological impairment that would prevent walking;
- Having any mental disability that prevents cognitive task Case group:
- Staying in an isolated room or having risk of infection (neutropenic, etc.),
- Any orthopedic or neurological impairment that could prevent walking;
- Having any mental disability that prevents cognitive task,
- Individuals with malignant hypertension or unstable heart disease (eg congestive heartfailure) will not be included in the study.
Study Design
Total Participants: 40
Study Start date:
March 01, 2021
Estimated Completion Date:
March 20, 2023
Study Description
Connect with a study center
Emel Taşvuran Horata
Afyonkarahisar, 03030
TurkeyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.